PT Pro Talk Ep 178 - Pain Medications in Low Back Pain: What’s Next? With Dr. Giovanni Ferreira
💭” Sciatica is a very good example of a subgroup of people with chronic back pain for which there isn’t any - or at least not reliable - evidence to guide a clinical decision regarding pain medicine.’’ - Dr. Giovanni Ferreira
Our guest Dr. Giovanni Ferreira BAppSc (Phty), PhD, is a Senior research fellow at The Institute for Musculoskeletal Health, Sydney Local Health District and The University of Sydney. Giovanni’s research investigates the effectiveness of innovative pharmacological and non-pharmacological interventions and new models of care to improve outcomes for people with musculoskeletal pain. In 2022, NewsCorp Australia recognised Dr Ferreira as one of Australia’s top 20 medical researchers under 40. Dr Ferreira holds leadership positions in the Australia & New Zealand Musculoskeletal (ANZMUSC), the Australia & New Zealand Low Back Pain Research Network (ANZBAC) as Co-Chair of the ECR committee and leader of the stratified (personalised) medicine theme, and Sydney Health Partner’s Musculoskeletal Clinical Academic Group.
📚You will learn about:
The effectiveness and recommended use of pain medications for chronic low back pain.
Research gaps and challenges in treating sciatica with medications.
The potential of precision medicine and biomarkers to improve treatment.
Current research and future directions in personalized pain management.
🔎 Dr. Giovanni Ferreira’s resources of information:
Low back pain and sciatica in over 16s: assessment and management
https://www.nice.org.uk/guidance/ng59/chapter/Recommendations-for-research
📲 Dr. Giovanni Ferreira’s contact information:
Email: giovanni.ferreira@sydney.edu.au
🐦X: @giovanni_ef
💻LinkedIn: Giovanni Ferreira
Email: giovanni.ferreira@sydney.edu.au
PS: To join the HEP interest list, please click here.
🎥Link to interview on Youtube
👉Here is the link for the quick survey
🎙Join our email list to receive podcast updates
📩Email mariana@ptprotalk.com
PT Pro Talk Podcast is only possible with the support of forward-looking and innovative companies like: NeckCare and SaraHealth